![](https://ml.globenewswire.com/media/63d35530-81c7-40bc-9801-c10b93ea3da3/small/logo-edesa-tm-rgb-jpg.jpg)
Edesa Biotech Reports Fiscal 1st Quarter 2025 Results
TORONTO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported financial results for the three …